No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
The Gabab Modulator market is a subset of the Central Nervous System Drugs market. Gabab Modulators are drugs that act on the GABA-B receptor, a type of neurotransmitter receptor found in the brain. These drugs are used to treat a variety of neurological disorders, including epilepsy, anxiety, and depression. They are also used to treat pain, spasticity, and other neurological conditions. Gabab Modulators are typically administered orally or intravenously, and can be taken as a single dose or in combination with other drugs.
Gabab Modulators are generally considered to be safe and effective, and have been approved by the FDA for use in the United States. However, they can cause side effects such as drowsiness, dizziness, and nausea.
Some companies in the Gabab Modulator market include AbbVie, AstraZeneca, GlaxoSmithKline, Merck, and Pfizer. Show Less Read more
